Cargando…
Leukocyte telomere length and plasma interleukin-1β and interleukin-18 levels in mild cognitive impairment and Alzheimer’s disease: new biomarkers for diagnosis and disease progression?
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8284289/ https://www.ncbi.nlm.nih.gov/pubmed/33318425 http://dx.doi.org/10.4103/1673-5374.300986 |
_version_ | 1783723371542872064 |
---|---|
author | Corbo, Rosa Maria Businaro, Rita Scarabino, Daniela |
author_facet | Corbo, Rosa Maria Businaro, Rita Scarabino, Daniela |
author_sort | Corbo, Rosa Maria |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8284289 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-82842892021-07-27 Leukocyte telomere length and plasma interleukin-1β and interleukin-18 levels in mild cognitive impairment and Alzheimer’s disease: new biomarkers for diagnosis and disease progression? Corbo, Rosa Maria Businaro, Rita Scarabino, Daniela Neural Regen Res Perspective Wolters Kluwer - Medknow 2020-12-12 /pmc/articles/PMC8284289/ /pubmed/33318425 http://dx.doi.org/10.4103/1673-5374.300986 Text en Copyright: © 2021 Neural Regeneration Research https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Perspective Corbo, Rosa Maria Businaro, Rita Scarabino, Daniela Leukocyte telomere length and plasma interleukin-1β and interleukin-18 levels in mild cognitive impairment and Alzheimer’s disease: new biomarkers for diagnosis and disease progression? |
title | Leukocyte telomere length and plasma interleukin-1β and interleukin-18 levels in mild cognitive impairment and Alzheimer’s disease: new biomarkers for diagnosis and disease progression? |
title_full | Leukocyte telomere length and plasma interleukin-1β and interleukin-18 levels in mild cognitive impairment and Alzheimer’s disease: new biomarkers for diagnosis and disease progression? |
title_fullStr | Leukocyte telomere length and plasma interleukin-1β and interleukin-18 levels in mild cognitive impairment and Alzheimer’s disease: new biomarkers for diagnosis and disease progression? |
title_full_unstemmed | Leukocyte telomere length and plasma interleukin-1β and interleukin-18 levels in mild cognitive impairment and Alzheimer’s disease: new biomarkers for diagnosis and disease progression? |
title_short | Leukocyte telomere length and plasma interleukin-1β and interleukin-18 levels in mild cognitive impairment and Alzheimer’s disease: new biomarkers for diagnosis and disease progression? |
title_sort | leukocyte telomere length and plasma interleukin-1β and interleukin-18 levels in mild cognitive impairment and alzheimer’s disease: new biomarkers for diagnosis and disease progression? |
topic | Perspective |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8284289/ https://www.ncbi.nlm.nih.gov/pubmed/33318425 http://dx.doi.org/10.4103/1673-5374.300986 |
work_keys_str_mv | AT corborosamaria leukocytetelomerelengthandplasmainterleukin1bandinterleukin18levelsinmildcognitiveimpairmentandalzheimersdiseasenewbiomarkersfordiagnosisanddiseaseprogression AT businarorita leukocytetelomerelengthandplasmainterleukin1bandinterleukin18levelsinmildcognitiveimpairmentandalzheimersdiseasenewbiomarkersfordiagnosisanddiseaseprogression AT scarabinodaniela leukocytetelomerelengthandplasmainterleukin1bandinterleukin18levelsinmildcognitiveimpairmentandalzheimersdiseasenewbiomarkersfordiagnosisanddiseaseprogression |